We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.76B
1-Year Est. Return 62.41%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+62.41%
3 Year Est. Return
+179.84%
5 Year Est. Return
+371.69%
10 Year Est. Return
+1,534.25%
AUM
$9.14B
AUM Growth
-$1.26B
Cap. Flow
-$1.81B
Cap. Flow %
-19.82%
Top 10 Hldgs %
41.43%
Holding
1,256
New
311
Increased
521
Reduced
82
Closed
288
Avg Time Held Equity + Options
2.1 quarters
Top 10 Avg Time Held Equity + Options
0.3 quarters
Top 20 Avg Time Held Equity + Options
0.6 quarters
Avg Time Held Equity only
2.1 quarters
Top 10 Avg Time Held Equity only
0.3 quarters
Top 20 Avg Time Held Equity only
0.6 quarters

Sector Composition

Rank Sector Weight
1 Technology 30.21%
2 Financials 21.65%
3 Healthcare 15.19%
4 Industrials 8.94%
5 Miscellaneous 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CLIM.WS icon
826
DELISTED
Climate Real Impact Solutions II Acquisition Corporation Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
CLIM.WS
$63K ﹤0.01%
+135,984
New +$86.1K
2022 Q1
0 quarters
AVAN.WS
827
DELISTED
Avanti Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AVAN.WS
$63K ﹤0.01%
257,392
+4,554
+2% +$1.64K
2021 Q1
4 quarters
AENTW icon
828
Alliance Entertainment Holding Corp Warrants
AENTW
$1.54M
$62K ﹤0.01%
183,256
+3,238
+2% +$1.18K
2021 Q2
3 quarters
AEACW
829
DELISTED
Authentic Equity Acquisition Corp. Warrant
AEACW
$61K ﹤0.01%
210,029
+3,716
+2% +$1.51K
2021 Q1
4 quarters
NUE icon
830
PUT
Nucor
NUE
$57.6B
$60K ﹤0.01%
+25,000
New +$3.07M
2022 Q1
0 quarters
SPECW icon
831
DELISTED
Spectaire Holdings, Inc. Warrant
SPECW
$60K ﹤0.01%
+262,510
New +$81.4K
2022 Q1
0 quarters
ATAQ.WS
832
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
$60K ﹤0.01%
+104,664
New +$67.6K
2022 Q1
0 quarters
LHC.WS
833
DELISTED
Leo Holdings Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
LHC.WS
$60K ﹤0.01%
169,979
+3,007
+2% +$1.48K
2021 Q1
4 quarters
CCVI.WS
834
DELISTED
Churchill Capital Corp VI Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50 per share
CCVI.WS
$59K ﹤0.01%
+104,595
New +$79K
2022 Q1
0 quarters
ENTFW
835
DELISTED
Enterprise 4.0 Technology Acquisition Corp. Warrant
ENTFW
$59K ﹤0.01%
163,341
-146,121
-47% -$61.6K
2021 Q4
1 quarter
EPHYW
836
DELISTED
Epiphany Technology Acquisition Corp. Warrant
EPHYW
$59K ﹤0.01%
174,337
+3,084
+2% +$1.24K
2021 Q1
4 quarters
RYAM icon
837
PUT
Rayonier Advanced Materials
RYAM
$495M
$58K ﹤0.01%
144,000
+30,900
+27% +$188K
2021 Q2
3 quarters
PMGMW icon
838
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$58K ﹤0.01%
261,507
+4,626
+2% +$1.57K
2021 Q1
4 quarters
BIOSW
839
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$58K ﹤0.01%
+257,374
New +$66.8K
2022 Q1
0 quarters
MONCW
840
DELISTED
Monument Circle Acquisition Corp. Warrant
MONCW
$58K ﹤0.01%
261,507
+4,626
+2% +$1.77K
2021 Q1
4 quarters
GNACW
841
DELISTED
Group Nine Acquisition Corp. Warrant
GNACW
$58K ﹤0.01%
174,337
+3,084
+2% +$1.33K
2021 Q1
4 quarters
PRPC.WS
842
DELISTED
CC Neuberger Principal Holdings III Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PRPC.WS
$57K ﹤0.01%
+83,682
New +$60K
2022 Q1
0 quarters
GFGDW
843
DELISTED
The Growth for Good Acquisition Corporation Warrant
GFGDW
$56K ﹤0.01%
+257,374
New +$69.4K
2022 Q1
0 quarters
SWETW
844
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
$56K ﹤0.01%
248,431
+4,395
+2% +$1.57K
2021 Q1
4 quarters
AEON.WS icon
845
DELISTED
AEON Biopharma Inc
AEON.WS
$55K ﹤0.01%
174,337
+3,084
+2% +$1.27K
2021 Q2
3 quarters
FACA.WS
846
DELISTED
Figure Acquisition Corp. I Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
FACA.WS
$54K ﹤0.01%
78,454
+1,388
+2% +$1.14K
2021 Q2
3 quarters
RCHGW
847
DELISTED
Recharge Acquisition Corp. Warrant
RCHGW
$54K ﹤0.01%
261,507
+4,626
+2% +$1.59K
2021 Q1
4 quarters
CRU.WS
848
DELISTED
Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CRU.WS
$54K ﹤0.01%
165,621
+2,930
+2% +$1.39K
2021 Q1
4 quarters
ARTEW
849
DELISTED
Artemis Strategic Investment Corporation Warrant
ARTEW
$53K ﹤0.01%
152,316
-53,991
-26% -$21.9K
2021 Q4
1 quarter
STET.WS
850
DELISTED
ST Energy Transition I Ltd. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50, included as part of the SAIL securities
STET.WS
$53K ﹤0.01%
+153,924
New +$61.1K
2022 Q1
0 quarters

Similar funds

UBS O'Connor's Q1 2022 Portfolio in Review

As of Q1 2022, UBS O'Connor held 1,256 positions worth $9.14B, down 12% from $10.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

UBS O'Connor withdrew a net $1.81B in Q1 2022, closing 288 positions and reducing 82 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $1.62B position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.

Against the trend, UBS O'Connor opened a new position in Citrix Systems Inc worth $433M.

  • UBS O'Connor's largest Q1 2022 buy was Citrix Systems Inc: 4,293,687 shares worth $433M.
  • UBS O'Connor added most to Cerner Corp in Q1 2022, an estimated $680M increase.
  • UBS O'Connor's biggest Q1 2022 reduction was EQT Corp, cutting an estimated $81.9M.
  • UBS O'Connor fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $1.62B.
  • UBS O'Connor's ten largest holdings make up 41% of its $9.14B portfolio in Q1 2022.
  • UBS O'Connor opened 311 new positions and closed 288 in Q1 2022.
  • UBS O'Connor's portfolio value fell 12% quarter-over-quarter to $9.14B.

Based on UBS O'Connor's 13F filing for Q1 2022, filed 16 May 2022.